Sensex

Nifty

USDINR

GBPINR

EURINR

BSE
NSE

Wednesday, 11 March 2026 02:03 PM	Asian-Paints2238.50	Hind-Unilever2158.90	ITC309.00	Trent3643.00	Larsen-and-Toubro3846.35	M-and-M3178.65	Reliance-Industries1398.10	Tata-Steel194.80	Titan-Company4163.50	SBI1095.00	Bharat-Electron455.20	Kotak-Mah-Bank385.30	Infosys1279.80	Bajaj-Finance900.80	Sun-PharmaInds1826.65	HDFC-Bank832.75	TCS2475.10	ICICI-Bank1298.50	Power-Grid-Corpn301.10	Maruti-Suzuki13483.00	Axis-Bank1265.95	HCL-Technologies1353.85	NTPC381.40	Bharti-Airtel1809.90	Tech-Mahindra1339.45	Adani-Ports1418.25	UltraTech-Cem11510.00	Bajaj-Finserv1796.35	Interglobe-Aviat4352.30	Eternal224.30
15 mins delay SENSEX 77,146.26 [-1,059.72]	-42.15 -1.85%	-32.90 -1.50%	-0.05 -0.02%	-70.10 -1.89%	-29.35 -0.76%	-113.65 -3.45%	-10.95 -0.78%	-0.25 -0.13%	-54.95 -1.30%	-17.35 -1.56%	-8.20 -1.77%	-6.65 -1.70%	-15.75 -1.22%	-39.45 -4.20%	13.65 0.75%	-16.35 -1.93%	-38.30 -1.52%	-13.75 -1.05%	2.65 0.89%	-387.05 -2.79%	-49.10 -3.73%	-7.70 -0.57%	4.10 1.09%	-41.25 -2.23%	3.05 0.23%	-5.85 -0.41%	-141.55 -1.21%	-71.60 -3.83%	-30.15 -0.69%	-1.80 -0.80%

Hot Pursuit

Scrips, which has significant changes during the market hours.

Lupin slips as Ankleshwar facility gets two observations from USFDA

09-Mar-26 10:14Hrs IST

The inspection was conducted between 2 March 2026 and 7 March 2026. Following the inspection, the US regulator issued Form 483, noting two observations at the facility.

The company said it will address the observations and respond to the US FDA within the stipulated timeframe. Lupin added that it remains committed to compliance with Current Good Manufacturing Practice (CGMP) standards across all its facilities.

Lupin is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. It specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients.

The pharmaceutical company reported a 37.46% surge in consolidated net profit to Rs 1,175.55 crore in Q3 FY26 as against Rs 855.16 crore posted in Q3 FY25. Total revenue from operations jumped 24.26% year-on-year to Rs 7,167.52 crore in the quarter ended 31 December 2025.

Powered by Capital Market - Live News

Attention Investor :

"Prevent unauthorised transactions in your account ; Update your mobile numbers/email IDs with Us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day” - Issued in the interest of Investors"

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"No need to issue cheques by investors while subscribing to Equity IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

"Contents which are exclusively for Non-Broking Products/Services, "Mutual Fund, Mutual Fund-SIP, Research reports, Insurance, etc. where the Member is just a distributor. These are not Exchange traded product and the Member is just acting as distributor. It should also state that all disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism."

A Muthoot M George Enterprise